Study of Origin	Sample ID	Cancer Type	Cancer Type Detailed	Protein Change	Annotation	Functional Impact	Mutation Type	Variant Type	Copy #	COSMIC	MS	VS	Center	Chromosome	Start Pos	End Pos	Ref	Var	HGVSg	HGVSc	Allele Freq (T)	Allele Freq (N)	Variant Reads	Ref Reads	Variant Reads (Normal)	Ref Reads (Normal)	# Mut in Sample	Exon	gnomAD	ClinVar	dbSNP	SIGNAL	Administration Of Drug Weeks	Diagnosis Age	AGENT	Durable Clinical Benefit	Event Type	Fraction Genome Altered	Histology	Molecular Smoking Signature	Neoantigen Burden	Nonsynonymous Mutation Burden	Note	Oncotree Code	PDL1 Expression	Progress Free Survival (Months)	Prior Treatment Of Cytotoxic Chemotherapy	Number of Samples Per Patient	Sex	Smoking History	Person Cigarette Smoking History Pack Year Value	Somatic Status	TMB (nonsynonymous)	Total Exonic Mutation Burden	Treatment best response	Clinical Trial	Driver Mutations	Gene Panel	Immunotherapy	Institute Source	Number Treatment Lines Prior To Receiving Impact Results	Metastatic Site	Overall Patient Histology	Primary Tumor Site	Recurrent/metastatic disease	Sample Class	Sample coverage	Sample pre any Lung Therapy	Sample Type	SO comments	Stage At Diagnosis	Target Therapy	Chemotherapy	Tumor Purity	Patient's Vital Status	Patient Current Age	Dosage	Mean Target Coverage Normal	Mean Target Coverage Tumor	Overall Response	Progression Free Status	Sample Collection Source	Person Cigarette Smoking History Pack Year Value	Tissue Source Site	Treatment Schedule	Age (yrs)	Best Overall Response	ECOG performance status	HLA_A1 allele	HLA_A2 alleles	HLA_B1 alleles	HLA_B2 alleles	HLA_C1 alleles	HLA_C2 alleles	PD-L1 expression (Percentage)	Predicted neoantigen burden	Smoking Status	FGA	IRB	Lines of treatment	Mutation Rate	PD-L1 Score (%)	Smoker	Treatment Type
Lung Adenocarcinoma (MSKCC, Science 2015)	AL4602	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	R58Q	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: tolerated, score: 0.37;Polyphen-2: impact: benign, score: 0.013	Missense_Mutation	SNP			NA	NA	NA	1	118165663	118165663	G	A	1:g.118165663G>A	ENST00000369448.3:c.173G>A	0.10		12	109		123	236	2/2	0.000003977		rs776281952		3	59	Pembrolizumab (Dose 10 mg/kg)	Durable clinical benefit beyond 6 months	Censored	0.6389	Adenocarcinoma	Transversion High	148	244	Self reported self status	LUAD	Strong(>or =50% membraneous staining)	8.4	0	1	Male	Former	34	Matched	7.83333333333	341	SD																																																	
Non-Small Cell Lung Cancer (MSKCC, J Clin Oncol 2018)	P-0005981-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	R58Q	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: tolerated, score: 0.37;Polyphen-2: impact: benign, score: 0.013	Missense_Mutation	SNP	Diploid		SOMATIC	Unknown	MSKCC	1	118165663	118165663	G	A	1:g.118165663G>A	ENST00000369448.3:c.173G>A	0.10		117	1084		540	10	2/2	0.000003977		rs776281952			60		YES		0.1121						LUAD		18.9		1	Male			Matched	9.78719697615					IMPACT410																							1:Progressed																	0.11	Clinical trial	1	9.433962264	50	Ever	Monotherapy
Non-Small Cell Lung Cancer (MSKCC, J Clin Oncol 2018)	P-0003562-T02-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	S369R	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: tolerated, score: 0.12;Polyphen-2: impact: benign, score: 0.034	Missense_Mutation	SNP	Diploid		SOMATIC	Unknown	MSKCC	1	118166597	118166597	C	A	1:g.118166597C>A	ENST00000369448.3:c.1107C>A	0.36		222	389		439	37	2/2						60		YES		0.4453						LUAD		9.2		1	Female			Matched	36.2126288117					IMPACT410																							1:Progressed																	0.45	Clinical trial	1	34.90566038		Ever	Monotherapy
Non-Small Cell Lung Cancer (MSKCC, J Clin Oncol 2018)	P-0011192-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	P100L	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: tolerated, score: 0.05;Polyphen-2: impact: possibly_damaging, score: 0.587	Missense_Mutation	SNP	Diploid		SOMATIC	Unknown	MSKCC	1	118165789	118165789	C	T	1:g.118165789C>T	ENST00000369448.3:c.299C>T	0.09		63	630		222	11	2/2						74		NO		0.0292						LUAD		2.27		1	Female			Matched	10.7659166738					IMPACT410																							1:Progressed																	0.03	Commercial	2	10.37735849		Ever	Monotherapy
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0005981-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	R58Q	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: tolerated, score: 0.37;Polyphen-2: impact: benign, score: 0.013	Missense_Mutation	SNP	Diploid		SOMATIC	NA	MSKCC	1	118165663	118165663	G	A	1:g.118165663G>A	ENST00000369448.3:c.173G>A							10	2/2	0.000003977		rs776281952			58				0.1121						LUAD				1	Male	Former heavy		Matched	9.78719697615			YES	KRAS	IMPACT410	YES	MSKCC	1	Lymph Node	Adenocarcinoma	Lung	YES	Tumor	1121	NO	Metastasis	Note: The NKX2-1 p.H37fs mutation frequency  suggests that the mutation occurs on the amplified allele	IV	NO	YES	70	AWD																													
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0000825-T01-IM3	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	R56L	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: deleterious, score: 0.04;Polyphen-2: impact: probably_damaging, score: 0.993	Missense_Mutation	SNP	Diploid		SOMATIC	NA	MSKCC	1	118165657	118165657	G	T	1:g.118165657G>T	ENST00000369448.3:c.167G>T							15	2/2	0.00000397703		rs565811357			49				0.0644						LUAD				1	Female	Never		Matched	16.637329509			NO	UNKNOWN DRIVER	IMPACT341	NO	MSKCC	3	Lymph Node	Adenocarcinoma	Lung	YES	Tumor	143	NO	Metastasis		IIIA	NO	YES	30	AWD																													
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0004382-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	R339C	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: deleterious, score: 0;Polyphen-2: impact: benign, score: 0.336	Missense_Mutation	SNP	Diploid		SOMATIC	NA	MSKCC	1	118166505	118166505	C	T	1:g.118166505C>T	ENST00000369448.3:c.1015C>T							38	2/2			rs865949572			77				0.3902						LUAD				1	Male	Former heavy		Matched	37.1913485094			NO	TSC1/2	IMPACT410	NO	MSKCC	0		Adenocarcinoma	Lung	YES	Tumor	471	YES	Primary		IV	NO	NO	30	DOD																													
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0003562-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	S369R	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: tolerated, score: 0.12;Polyphen-2: impact: benign, score: 0.034	Missense_Mutation	SNP	Diploid		SOMATIC	NA	MSKCC	1	118166597	118166597	C	A	1:g.118166597C>A	ENST00000369448.3:c.1107C>A							37	2/2						60				0.6842						LUAD				1	Male	Former heavy		Matched	36.2126288117			YES	RAF1	IMPACT410	YES	MSKCC	0		Adenocarcinoma	Lung	YES	Tumor	629	YES	Primary		IV	NO	NO	90	AWD																													
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0004339-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	V69I	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: tolerated, score: 0.59;Polyphen-2: impact: benign, score: 0.005	Missense_Mutation	SNP	Diploid		SOMATIC	NA	MSKCC	1	118165695	118165695	G	A	1:g.118165695G>A	ENST00000369448.3:c.205G>A							13	2/2	0.000014140971343321572		rs745917069			51				0.0540						LUAD				1	Female	Never		Matched	12.723356069			NO	UNKNOWN DRIVER	IMPACT410	NO	MSKCC	0		Adenocarcinoma	Lung	YES	Tumor	680	YES	Primary		IV	NO	YES	50	AWD																													
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0004891-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	S74F	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: deleterious, score: 0.01;Polyphen-2: impact: probably_damaging, score: 0.995	Missense_Mutation	SNP	Diploid		SOMATIC	NA	MSKCC	1	118165711	118165711	C	T	1:g.118165711C>T	ENST00000369448.3:c.221C>T							11	2/2						51				0.2811						LUAD				1	Female	Former heavy		Matched	10.7659166738			NO	KRAS	IMPACT410	NO	MSKCC	0	Neck	Adenocarcinoma	Lung	YES	Tumor	523	YES	Metastasis	Note: The KEAP1 exon4 mutations all occur in cis (same allele).    Note: Copy number profile is suggestive of broad copy number gains on Chromosome arms 8q and 15q.	IV	NO	YES	40	DOD																													
